Completed OBSERVATIONAL NCT02028728

BIOFLOW III Satellite-Italy Orsiro Stent System

Safety and Performance Registry for an All Comers Patient Population With the Limus Eluting Orsiro Stent Within Daily Clinical Practice III-Italy

Sponsor: Biotronik Italia S.p.A.

Conditions Coronary Artery Diseases

Updated 8 times since 2017 Last updated: Sep 28, 2017 Started: Mar 31, 2014 Primary completion: Jul 31, 2016 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02028728, this observational or N/A phase trial focuses on Coronary Artery Diseases and remains completed. Sponsored by Biotronik Italia S.p.A., it has been updated 8 times since 2014, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Oct 2017 — Apr 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jan 2017 — Oct 2017 [monthly]

Active Not Recruiting NA

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biotronik Italia S.p.A.

Data source: Biotronik Italia S.p.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bari, Italy , Campobasso, Italy , Catanzaro, Italy , Isernia, Italy , Legnano, Italy , Magenta, Italy , Milan, Italy , Napoli, Italy , Pesaro, Italy , Roma, Italy and 3 more locations